Have your own idea? Try our Stock Screener
Israeli (TA) Biotech Industry Analysis
UpdatedJul 03, 2026
DataAggregated Company Financials
Companies11
- 7D4.4%
- 3M-13.2%
- 1Y-13.6%
- YTD-7.8%
The Biotech industry is up 5.5% in the last week, with Kamada up 6.0%. During this same period, the Matricelf underperformed, falling 8.2%. In the past year, the industry is down 11%. Looking forward, earnings are forecast to grow by 17% annually.
Industry Valuation and Performance
Has the Israeli Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 03 Jul 2026 | ₪2.0b | ₪555.9m | -₪115,022,672.00 | 13.1x | -17.4x | 3.6x |
| Sun, 31 May 2026 | ₪2.2b | ₪522.9m | -₪87,845,690.50 | 7.3x | -24.9x | 4.2x |
| Tue, 28 Apr 2026 | ₪2.4b | ₪554.1m | -₪57,774,294.20 | 6.9x | -40.8x | 4.3x |
| Thu, 26 Mar 2026 | ₪2.4b | ₪580.3m | -₪64,021,240.40 | 14.6x | -37.4x | 4.1x |
| Sat, 21 Feb 2026 | ₪2.7b | ₪611.5m | -₪60,166,931.20 | 15.3x | -44.6x | 4.4x |
| Mon, 19 Jan 2026 | ₪2.6b | ₪616.6m | -₪60,219,802.80 | 14x | -42.6x | 4.2x |
| Wed, 17 Dec 2025 | ₪2.1b | ₪637.7m | -₪66,586,592.50 | 12.6x | -32.1x | 3.3x |
| Fri, 14 Nov 2025 | ₪2.1b | ₪655.5m | -₪88,754,359.00 | 12.8x | -23.8x | 3.2x |
| Sun, 12 Oct 2025 | ₪2.2b | ₪653.8m | -₪94,479,571.00 | 12.9x | -22.8x | 3.3x |
| Tue, 09 Sep 2025 | ₪2.3b | ₪659.5m | -₪97,130,979.00 | 13.3x | -23.2x | 3.4x |
| Thu, 07 Aug 2025 | ₪2.2b | ₪682.3m | -₪129,507,003.70 | 14.8x | -16.7x | 3.2x |
| Sat, 05 Jul 2025 | ₪2.3b | ₪664.8m | -₪128,489,977.30 | 16.3x | -17.6x | 3.4x |
| Mon, 02 Jun 2025 | ₪2.2b | ₪698.3m | -₪130,433,551.40 | 14.6x | -16.8x | 3.1x |
| Wed, 30 Apr 2025 | ₪2.1b | ₪725.0m | -₪163,211,330.00 | 15.6x | -13.2x | 3x |
| Fri, 28 Mar 2025 | ₪2.2b | ₪709.6m | -₪219,639,640.00 | 16.2x | -10.1x | 3.1x |
| Sun, 23 Feb 2025 | ₪2.3b | ₪679.0m | -₪227,411,887.20 | 16.8x | -10.2x | 3.4x |
| Tue, 21 Jan 2025 | ₪2.2b | ₪678.5m | -₪227,307,063.80 | 15.7x | -9.8x | 3.3x |
| Thu, 19 Dec 2024 | ₪1.9b | ₪682.8m | -₪225,737,632.40 | 13.6x | -8.3x | 2.7x |
| Sat, 16 Nov 2024 | ₪2.1b | ₪700.2m | -₪255,373,146.50 | 13.6x | -8.2x | 3x |
| Mon, 14 Oct 2024 | ₪2.0b | ₪689.6m | -₪258,640,591.70 | 13x | -7.7x | 2.9x |
| Wed, 11 Sep 2024 | ₪2.1b | ₪689.0m | -₪258,135,025.50 | 13.1x | -8x | 3x |
| Fri, 09 Aug 2024 | ₪2.1b | ₪650.8m | -₪333,570,086.80 | 16.6x | -6.2x | 3.2x |
| Sun, 07 Jul 2024 | ₪2.1b | ₪635.4m | -₪327,607,899.50 | 16.5x | -6.3x | 3.3x |
| Tue, 04 Jun 2024 | ₪2.1b | ₪628.5m | -₪327,084,835.30 | 16x | -6.4x | 3.3x |
| Thu, 02 May 2024 | ₪2.1b | ₪579.6m | -₪408,234,408.10 | 22.3x | -5.2x | 3.7x |
| Sat, 30 Mar 2024 | ₪2.3b | ₪571.9m | -₪387,758,675.20 | 23.2x | -6x | 4.1x |
| Mon, 26 Feb 2024 | ₪2.5b | ₪578.1m | -₪363,630,415.40 | 63x | -6.8x | 4.3x |
| Wed, 24 Jan 2024 | ₪2.4b | ₪642.1m | -₪405,745,702.00 | 61.1x | -5.8x | 3.7x |
| Fri, 22 Dec 2023 | ₪2.4b | ₪620.9m | -₪396,547,626.00 | 62.3x | -6x | 3.8x |
| Sun, 19 Nov 2023 | ₪2.1b | ₪635.7m | -₪381,920,969.00 | 57.5x | -5.6x | 3.3x |
| Tue, 17 Oct 2023 | ₪2.1b | ₪644.4m | -₪425,239,434.00 | 74.4x | -5x | 3.3x |
| Thu, 14 Sep 2023 | ₪2.2b | ₪621.8m | -₪381,612,902.00 | 70.6x | -5.9x | 3.6x |
| Sat, 12 Aug 2023 | ₪1.9b | ₪553.4m | -₪394,409,361.00 | 60.3x | -4.8x | 3.4x |
| Mon, 10 Jul 2023 | ₪1.9b | ₪547.5m | -₪395,034,706.00 | n/a | -4.8x | 3.5x |
Price to Earnings Ratio
-4.8x
Current Industry PE
- Investors are relatively neutral on the Israeli Biotechs industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PS ratio of 3.5x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have improved over the last three years.
- Meanwhile revenues have remained mostly flat.
- This means that companies overall are more efficiently conducting business since losses are shrinking while sales have been flat.
Industry Trends
Which industries have driven the changes within the Israeli Healthcare industry?
| IL Market | 4.13% | |
| Healthcare | 3.56% | |
| Biotech | 4.43% | |
| Biotech | 4.43% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| KMDA Kamada | ₪22.57 | 6.0% +₪73.3m | -13.1% | PE21.3x | |
| BONS Bonus BioGroup | ₪0.34 | 3.9% +₪15.2m | 48.1% | PE-16.5x | |
| CANF Can-Fite BioPharma | ₪6.48 | 41.0% +₪8.1m | -82.0% | PS22.9x | |
| EVGN Evogene | ₪1.32 | 8.9% +₪1.1m | -71.1% | PS2.5x |